News

Fulcrum Therapeutics Announces Results from ReDUX4 Trial with Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) Demonstrating Slowed Disease Progression and Improved Function

Primary endpoint, change in DUX4-driven gene expression which was included as an experimental biomarker, was not metLosmapimod showed statistically significant*...

Aravive Announces Positive Initial Results from Phase 1b Portion of the Phase1b/2 Study of AVB-500 in Combination with Cabozantinib in Clear Cell Renal Carcinoma

Encouraging Pharmacokinetics, Pharmacodynamics and Safety Profile at 15mg/kg of AVB-500HOUSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Aravive Inc. (Nasdaq: ARAV),...

Modernizing Medicine Ranks #1 for Integrated Practice Management, Revenue Cycle Management and EHR in Surgical Specialties by Black Book Research for the 3rd Year in a Row

error: Content is protected !!